Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C, Chronic

Explore clinical trials studying Hepatitis C, Chronic. Study availability and eligibility vary by location and protocol.

699 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C, Chronic trial results

Completed

Interferon α 2b Pharmacovigilance Study

NCT01841775

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Hospital Federal de Bonsucesso (Bonsucesso Federal Hospital) Rio de Janeiro, Brazil
  • Hospital Universitário Clementino Fraga Filho (Clementino Fraga Filho University Hospital) Rio de Janeiro, Brazil
View Trial Details
Completed

Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment

NCT00680342

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
View Trial Details
Completed

100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)

NCT01378104

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations
  • Soonchunghyang University Hospital Bucheon-si, South Korea
  • Hallym University Chunchun Medical center Chunchun, South Korea
  • Keimyung University hospital Daegu, South Korea
  • Kyungpook National University Hospital Daegu, South Korea
View all 14 locations
View Trial Details
Completed

Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C

NCT01140997

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations
  • 302 Military Hospital Beijing, China
  • Beijing Youan Hospital, Capital Medical University Beijing, China
  • Beijing Youyi Hospital, Capital Medical University Beijing, China
  • Peking University First Hospital Beijing, China
View all 38 locations
View Trial Details
Completed

A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1

NCT01448200

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Investigational site Costa Mesa, California, United States
  • Investigational site Sacramento, California, United States
  • Investigational site San Francisco, California, United States
  • Investigational Site San Antonio, Texas, United States
View Trial Details

Related conditions